R/C TIOTROPIN 3D

Description

R/C TIOTROPIN 3D is an advanced triple-combination inhaler formulated with Ciclesonide (400 mcg), Formoterol (12 mcg), and Tiotropium (18 mcg) to provide comprehensive management of chronic respiratory conditions such as Chronic Obstructive Pulmonary Disease (COPD) and moderate to severe asthma. This combination therapy targets multiple pathways in respiratory management: Ciclesonide, an inhaled corticosteroid (ICS), reduces airway inflammation; Formoterol, a long-acting beta2-agonist (LABA), relaxes bronchial muscles for easier airflow; and Tiotropium, an anticholinergic bronchodilator, ensures long-lasting bronchodilation. Together, they offer enhanced lung function, symptom control, and improved quality of life for patients with chronic respiratory disorders. Uses R/C TIOTROPIN 3D is indicated for: Long-term management of moderate to severe asthma. Maintenance therapy for COPD, including chronic bronchitis and emphysema. Reduction of wheezing, breathlessness, and chest tightness. Prevention of asthma and COPD exacerbations. Improvement of overall respiratory function in patients who require both anti-inflammatory and bronchodilator therapy. Note: This inhaler is intended for maintenance therapy and is not suitable for immediate relief during acute asthma attacks. Benefits Triple-Action Formula: Combines anti-inflammatory, long-acting bronchodilator, and anticholinergic effects for complete respiratory management. Rapid and Sustained Relief: Formoterol acts quickly to relieve bronchospasm, while Tiotropium provides 24-hour bronchodilation. Reduces Inflammation: Ciclesonide targets airway inflammation, minimizing flare-ups and mucus buildup. Improves Lung Function: Enhances airflow and oxygen delivery for easier breathing. Prevents Exacerbations: Reduces the frequency and severity of asthma or COPD attacks. Convenient and Effective: Once-daily dosing of Tiotropium combined with twice-daily Formoterol and Ciclesonide ensures optimal symptom control. Dosage Adults: The usual recommended dose is one inhalation twice daily via a metered-dose inhaler, or as prescribed by a healthcare professional. Shake the inhaler well before each use, exhale completely, and inhale deeply through the mouthpiece. Rinse your mouth with water after inhalation to reduce the risk of oral thrush. Do not exceed the prescribed dose or use for immediate symptom relief during sudden attacks. Proper inhalation technique is critical for effective drug delivery. Side Effects Common side effects may include: Throat irritation or hoarseness Dry mouth Headache or dizziness Mild tremors or palpitations Oral thrush (fungal infection in the mouth) Serious side effects are rare but may include allergic reactions, rapid heartbeat, or difficulty breathing. Seek immediate medical attention if severe symptoms occur. Precautions and Warning Pregnancy & Breastfeeding: Use only under medical supervision. Heart Conditions: Consult a doctor if you have hypertension, arrhythmia, or cardiovascular disorders. Diabetes & Thyroid Disorders: Formoterol may affect blood sugar and thyroid levels; monitor regularly. Not for Acute Attacks: Keep a rescue inhaler for sudden asthma symptoms. Allergies: Avoid if allergic to Ciclesonide, Formoterol, Tiotropium, or any excipients. Storage: Store in a cool, dry place below 30°C, away from sunlight, and out of children’s reach. Conclusion R/C TIOTROPIN 3D (Ciclesonide 400 mcg + Formoterol 12 mcg + Tiotropium 18 mcg) is a clinically proven triple-combination inhaler that delivers anti-inflammatory, bronchodilator, and anticholinergic effects in a single, convenient therapy. It effectively manages symptoms of COPD and moderate to severe asthma, improves lung function, and reduces the risk of flare-ups, ensuring patients breathe comfortably and maintain an active lifestyle. With regular use as prescribed, R/C TIOTROPIN 3D offers a comprehensive solution for long-term respiratory health and enhanced quality of life.